Glucagon like peptide 1 receptor agonists in patients with inflammatory bowel disease: safety, clinical effectiveness and anti-inflammatory mechanisms.
- DOI
- 10.3389/fgstr.2026.1864456
- Published
- 2026
- Container
- Frontiers in gastroenterology (Lausanne, Switzerland)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fgstr.2026.1864456,
title = {Glucagon like peptide 1 receptor agonists in patients with inflammatory bowel disease: safety, clinical effectiveness and anti-inflammatory mechanisms.},
author = {Fernando S and Zhao J and Josloff K and Zubair N and Desai A and Shivashankar R and Kozuch PL and Choudhary C and Lichtenstein G and Sehgal P},
year = {2026},
journal = {Frontiers in gastroenterology (Lausanne, Switzerland)},
doi = {10.3389/fgstr.2026.1864456},
url = {https://doi.org/10.3389/fgstr.2026.1864456}
}RIS
TY - JOUR TI - Glucagon like peptide 1 receptor agonists in patients with inflammatory bowel disease: safety, clinical effectiveness and anti-inflammatory mechanisms. AU - Fernando S AU - Zhao J AU - Josloff K AU - Zubair N AU - Desai A AU - Shivashankar R AU - Kozuch PL AU - Choudhary C AU - Lichtenstein G AU - Sehgal P PY - 2026 JO - Frontiers in gastroenterology (Lausanne, Switzerland) DO - 10.3389/fgstr.2026.1864456 UR - https://doi.org/10.3389/fgstr.2026.1864456 ER -
APA
S, F., J, Z., K, J., N, Z., A, D., R, S., PL, K., C, C., G, L., & P, S. (2026). Glucagon like peptide 1 receptor agonists in patients with inflammatory bowel disease: safety, clinical effectiveness and anti-inflammatory mechanisms.. Frontiers in gastroenterology (Lausanne, Switzerland). https://doi.org/10.3389/fgstr.2026.1864456
Source records
- pubmed · retrieved 2026-09-26T13:09:30.836Z